These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33387360)

  • 21. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries.
    Koshiba A; Mori T; Okimura H; Akiyama K; Kataoka H; Takaoka O; Ito F; Matsushima H; Kusuki I; Kitawaki J
    J Obstet Gynaecol Res; 2018 Oct; 44(10):1970-1976. PubMed ID: 29992672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
    Yamanaka A; Hada T; Matsumoto T; Kanno K; Shirane A; Yanai S; Nakajima S; Ebisawa K; Ota Y; Andou M
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():51-55. PubMed ID: 28728071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study.
    Cho B; Roh JW; Park J; Jeong K; Kim TH; Kim YS; Kwon YS; Cho CH; Park SH; Kim SH
    Reprod Sci; 2020 Mar; 27(3):905-915. PubMed ID: 32052358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
    Morotti M; Sozzi F; Remorgida V; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():188-92. PubMed ID: 25461377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical Analysis of the Effect of Dienogest on Ovarian Endometriotic Cysts.
    Nguyen TT; Hachisuga T; Urabe R; Ueda T; Kurita T; Kagami S; Kawagoe T; Hisaoka M
    J UOEH; 2016; 38(4):271-278. PubMed ID: 27980309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β.
    Mita S; Shimizu Y; Sato A; Notsu T; Imada K; Kyo S
    Fertil Steril; 2014 Feb; 101(2):595-601. PubMed ID: 24289989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacology of dienogest.
    Ruan X; Seeger H; Mueck AO
    Maturitas; 2012 Apr; 71(4):337-44. PubMed ID: 22364708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NLRP3 concentration, oxidants, and antioxidants in plasma of endometriosis patients undergoing treatment with dienogest.
    Ajdary M; Kashi AM; Derakhshan R; Chaichian S; Tahermanesh K; Mehdizadeh M; Minaeian S; Govahi A
    J Gynecol Obstet Hum Reprod; 2024 Mar; 53(3):102744. PubMed ID: 38346495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density.
    Seo JW; Lee DY; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():9-12. PubMed ID: 28314166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside.
    Laganà AS; Vitale SG; Granese R; Palmara V; Ban Frangež H; Vrtačnik-Bokal E; Chiofalo B; Triolo O
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):593-596. PubMed ID: 28537213
    [No Abstract]   [Full Text] [Related]  

  • 32. Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells.
    Grandi G; Mueller M; Bersinger N; Papadia A; Nirgianakis K; Cagnacci A; McKinnon B
    Am J Reprod Immunol; 2016 Oct; 76(4):292-8. PubMed ID: 27515307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas.
    Ozaki R; Kumakiri J; Jinushi M; Ikuma S; Murakami K; Kawasaki Y; Kitade M
    Arch Gynecol Obstet; 2020 Oct; 302(4):969-976. PubMed ID: 32661756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.
    Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
    Int J Gynaecol Obstet; 2012 Jun; 117(3):228-33. PubMed ID: 22459918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
    Grandi G; Mueller MD; Bersinger NA; Facchinetti F; McKinnon BD
    Gynecol Endocrinol; 2017 Sep; 33(9):712-715. PubMed ID: 28412861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells.
    Mita S; Nakakuki M; Ichioka M; Shimizu Y; Hashiba M; Miyazaki H; Kyo S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():65-70. PubMed ID: 28482330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid metabolism during treatment of endometriosis with the progestin dienogest.
    Köhler G; Göretzlehner G; Brachmann K
    Acta Obstet Gynecol Scand; 1989; 68(7):633-5. PubMed ID: 2631529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR.
    Choi J; Jo M; Lee E; Lee DY; Choi D
    Fertil Steril; 2015 Sep; 104(3):655-64.e1. PubMed ID: 26051103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis.
    Miyashita M; Koga K; Takamura M; Izumi G; Nagai M; Harada M; Hirata T; Hirota Y; Fujii T; Osuga Y
    Gynecol Endocrinol; 2014 Sep; 30(9):644-8. PubMed ID: 24805834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study.
    Moehner S; Becker K; Lange JA; von Stockum S; Heinemann K
    Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():212-217. PubMed ID: 32559605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.